Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19 (COVCKD)

R

Region MidtJylland Denmark

Status

Unknown

Conditions

Terminal Renal Insufficiency
COVID

Study type

Observational

Funder types

Other

Identifiers

NCT04367714
FHM-1-2020

Details and patient eligibility

About

Determination of IgM and IgG antibodies against SARS-CoV-2 in dialysis patients by continous monitoring in the period from March 2020 to december 2020

Full description

Blood samples are collected every 14 days

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Dialysis

Exclusion criteria

Not willing to give consent

Trial contacts and locations

0

Loading...

Central trial contact

Frank Mose, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems